Joanne Wuensch
Stock Analyst at Citigroup
(4.40)
# 328
Out of 4,962 analysts
404
Total ratings
64.07%
Success rate
12.08%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Neutral | $10 → $11 | $11.93 | -7.80% | 19 | Aug 21, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $3.6 → $4.5 | $4.23 | +6.38% | 12 | Aug 21, 2025 | |
| MDT Medtronic | Maintains: Buy | $99 → $101 | $92.71 | +8.94% | 21 | Aug 21, 2025 | |
| JNJ Johnson & Johnson | Maintains: Buy | $185 → $200 | $179.29 | +11.55% | 13 | Aug 21, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $167 → $183 | $169.12 | +8.21% | 20 | Aug 21, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $89 → $93 | $75.22 | +23.64% | 6 | Jul 31, 2025 | |
| PEN Penumbra | Maintains: Neutral | $320 → $285 | $264.74 | +7.65% | 25 | Jul 9, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Neutral | $38 → $47 | $43.64 | +7.71% | 7 | Jul 9, 2025 | |
| BAX Baxter International | Maintains: Neutral | $34 → $32 | $24.54 | +30.40% | 21 | Jul 9, 2025 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $13 → $15 | $14.94 | +0.40% | 6 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $71 → $90 | $56.37 | +59.66% | 8 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $443 → $455 | $394.22 | +15.42% | 14 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $1.69 | +145.56% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $590 → $650 | $476.16 | +36.51% | 17 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $380 | $330.77 | +14.88% | 16 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $95 | $81.83 | +16.09% | 20 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $102 | $82.26 | +24.00% | 14 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $119 → $125 | $106.17 | +17.74% | 35 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $133 → $140 | $110.58 | +26.61% | 6 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $110 | $75.22 | +46.24% | 20 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $160 | $132.59 | +20.67% | 20 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $132 → $162 | $94.15 | +72.07% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $16 → $22 | $14.86 | +48.05% | 14 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $134 → $120 | $107.71 | +11.41% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $199.66 | +25.21% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $82.02 | -15.87% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $293.73 | -56.76% | 6 | Dec 10, 2018 |
Tandem Diabetes Care
Aug 21, 2025
Maintains: Neutral
Price Target: $10 → $11
Current: $11.93
Upside: -7.80%
Sight Sciences
Aug 21, 2025
Maintains: Neutral
Price Target: $3.6 → $4.5
Current: $4.23
Upside: +6.38%
Medtronic
Aug 21, 2025
Maintains: Buy
Price Target: $99 → $101
Current: $92.71
Upside: +8.94%
Johnson & Johnson
Aug 21, 2025
Maintains: Buy
Price Target: $185 → $200
Current: $179.29
Upside: +11.55%
iRhythm Technologies
Aug 21, 2025
Maintains: Buy
Price Target: $167 → $183
Current: $169.12
Upside: +8.21%
GE HealthCare Technologies
Jul 31, 2025
Maintains: Buy
Price Target: $89 → $93
Current: $75.22
Upside: +23.64%
Penumbra
Jul 9, 2025
Maintains: Neutral
Price Target: $320 → $285
Current: $264.74
Upside: +7.65%
Establishment Labs Holdings
Jul 9, 2025
Maintains: Neutral
Price Target: $38 → $47
Current: $43.64
Upside: +7.71%
Baxter International
Jul 9, 2025
Maintains: Neutral
Price Target: $34 → $32
Current: $24.54
Upside: +30.40%
Bausch + Lomb
Jul 9, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $14.94
Upside: +0.40%
Jul 9, 2025
Upgrades: Buy
Price Target: $71 → $90
Current: $56.37
Upside: +59.66%
May 22, 2025
Maintains: Buy
Price Target: $443 → $455
Current: $394.22
Upside: +15.42%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $1.69
Upside: +145.56%
May 22, 2025
Maintains: Buy
Price Target: $590 → $650
Current: $476.16
Upside: +36.51%
May 22, 2025
Maintains: Buy
Price Target: $320 → $380
Current: $330.77
Upside: +14.88%
May 22, 2025
Maintains: Buy
Price Target: $84 → $95
Current: $81.83
Upside: +16.09%
May 22, 2025
Maintains: Buy
Price Target: $82 → $102
Current: $82.26
Upside: +24.00%
May 22, 2025
Maintains: Buy
Price Target: $119 → $125
Current: $106.17
Upside: +17.74%
May 22, 2025
Upgrades: Buy
Price Target: $133 → $140
Current: $110.58
Upside: +26.61%
Mar 7, 2025
Maintains: Buy
Price Target: $115 → $110
Current: $75.22
Upside: +46.24%
Mar 4, 2025
Maintains: Buy
Price Target: $135 → $160
Current: $132.59
Upside: +20.67%
Dec 11, 2024
Upgrades: Buy
Price Target: $132 → $162
Current: $94.15
Upside: +72.07%
Nov 5, 2024
Maintains: Sell
Price Target: $16 → $22
Current: $14.86
Upside: +48.05%
Jul 10, 2024
Maintains: Neutral
Price Target: $134 → $120
Current: $107.71
Upside: +11.41%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $199.66
Upside: +25.21%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $82.02
Upside: -15.87%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $293.73
Upside: -56.76%